Dr Mellinghof presents on epidermal growth factor receptor mutations that occur in glioblastoma and how they differ from those that occur in lung cancers.  This finding, which was presented at the AACR 2012 Annual Meeting, may explain the lack of response to epidermal growth factor receptor inhibitors seen in glioblastoma.